Last updated on May 2018

Evaluation of ALX-0171 in Japanese Children Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection


Brief description of study

The objectives of this study are:

  • to evaluate the safety, tolerability, and systemic pharmacokinetics (PK) of different doses of inhaled ALX-0171 in Japanese infants and young children hospitalized for respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI).
  • to evaluate the antiviral effect, clinical activity, immunogenicity, and pharmacodynamics (PD) of different doses of inhaled ALX-0171 in Japanese infants and young children hospitalized for RSV LRTI.

Clinical Study Identifier: NCT03418571

Contact Investigators or Research Sites near you

Start Over

Ablynx NV Belgium

Investigator Site
Kurume-shi, Japan
  Connect »